Alaunos Therapeutics, Inc. (TCRT) SEC filings
TCRT SEC filings moved a median of -0.80% by the close. TCRT SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the TCRT overview →
67 measured TCRT SEC filing events.
Where these TCRT SEC filings landedvs 67 measured TCRT SEC filing reactions
| Middle 50% of TCRT SEC filing reactions | -4.54% to +3.88% |
|---|---|
| Median reaction (to close) | -0.80% |
| Measured reactions | 67 |
Point-in-time · zero look-ahead
Half of the 67 TCRT SEC filing events with a measured close landed between -4.54% and +3.88%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Alaunos Therapeutics, For: Oct 13 | SEC filing · Form 8-K | +17.14% | +73.14% | |
| Form 8-K Alaunos Therapeutics, For: Oct 05 | SEC filing · Form 8-K | +5.07% | +35.40% | |
| Form 8-K Alaunos Therapeutics, For: Sep 18 | SEC filing · Form 8-K | -1.49% | -4.96% | |
| Form 8-K Alaunos Therapeutics, For: Sep 16 | SEC filing · Form 8-K | -0.74% | +18.52% | |
| Form 10-Q Alaunos Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -2.44% | -6.83% | |
| Form S-8 Alaunos Therapeutics, | SEC filing · Form S-8 | +0.00% | +0.94% | |
| Form 8-K Alaunos Therapeutics, For: Jun 29 | SEC filing · Form 8-K | +3.41% | +7.73% | |
| Form 8-K Alaunos Therapeutics, For: May 26 | SEC filing · Form 8-K | -4.35% | -3.16% | |
| Form 8-K Alaunos Therapeutics, For: May 18 | SEC filing · Form 8-K | — | -0.80% | |
| Form 10-Q Alaunos Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | — | -0.80% | |
| Form 10-K/A Alaunos Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.39% | +1.95% | |
| Form 8-K Alaunos Therapeutics, For: Apr 09 | SEC filing · Form 8-K | +4.58% | -0.35% | |
| Form 10-K Alaunos Therapeutics, For: Dec 31 | SEC filing · Form 10-K | — | -0.34% | |
| Form 8-K Alaunos Therapeutics, For: Mar 02 | SEC filing · Form 8-K | — | +6.07% | |
| Form 8-K Alaunos Therapeutics, For: Jan 08 | SEC filing · Form 8-K | +5.76% | +7.27% | |
| Form 8-K Alaunos Therapeutics, For: Dec 17 | SEC filing · Form 8-K | +1.68% | +2.92% | |
| Form 10-Q Alaunos Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.09% | +7.69% | |
| Form S-3/A Alaunos Therapeutics, | SEC filing · Form S-3 | +0.00% | +4.54% | |
| Form S-1 Alaunos Therapeutics, | SEC filing · Form S-1 | +0.24% | -0.78% | |
| Form S-3/A Alaunos Therapeutics, | SEC filing · Form S-3 | +2.82% | +6.05% | |
| Form S-3/A Alaunos Therapeutics, | SEC filing · Form S-3 | — | +4.07% | |
| Form S-3 Alaunos Therapeutics, | SEC filing · Form S-3 | +0.52% | -4.54% | |
| Form 8-K Alaunos Therapeutics, For: Aug 19 | SEC filing · Form 8-K | +0.52% | -4.54% | |
| Form 10-Q Alaunos Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.42% | -6.25% | |
| Form 8-K Alaunos Therapeutics, For: Jul 16 | SEC filing · Form 8-K | +0.00% | +3.68% | |
| Form 8-K Alaunos Therapeutics, For: Jul 15 | SEC filing · Form 8-K | -0.58% | -6.63% | |
| Form 8-K Alaunos Therapeutics, For: Jul 03 | SEC filing · Form 8-K | +3.07% | +2.25% | |
| Form 8-K Alaunos Therapeutics, For: Jul 01 | SEC filing · Form 8-K | +0.20% | +2.25% | |
| Form 8-K Alaunos Therapeutics, For: Jun 20 | SEC filing · Form 8-K | +0.30% | +13.32% | |
| Form 8-K Alaunos Therapeutics, For: Jun 24 | SEC filing · Form 8-K | +0.30% | +13.32% | |
| Form 8-K Alaunos Therapeutics, For: Jun 09 | SEC filing · Form 8-K | — | +3.69% | |
| Form 8-K Alaunos Therapeutics, For: May 19 | SEC filing · Form 8-K | +0.21% | +1.54% | |
| Form ARS Alaunos Therapeutics, For: Dec 31 | SEC filing · Form ARS | -0.76% | -3.05% | |
| Form DEF 14A Alaunos Therapeutics, For: Jul 03 | SEC filing · Form DEF | -0.76% | -3.05% | |
| Form DEFA14A Alaunos Therapeutics, | SEC filing · Form DEFA14A | -0.76% | -3.05% | |
| Form 10-Q Alaunos Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.02% | -3.07% | |
| Form PRE 14A Alaunos Therapeutics, For: Jul 03 | SEC filing · Form PRE | -1.76% | -3.39% | |
| Form 10-K/A Alaunos Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -7.82% | |
| Form 8-K Alaunos Therapeutics, For: Apr 15 | SEC filing · Form 8-K | +0.00% | -3.69% | |
| Form 8-K Alaunos Therapeutics, For: Apr 15 | SEC filing · Form 8-K | -1.40% | -6.32% | |
| Form 8-K Alaunos Therapeutics, For: Apr 11 | SEC filing · Form 8-K | +0.79% | -10.36% | |
| Form 8-K Alaunos Therapeutics, For: Apr 07 | SEC filing · Form 8-K | +0.79% | -10.36% | |
| Form 10-K Alaunos Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +50.00% | |
| Form 10-Q Alaunos Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -1.78% | |
| Form 8-K Alaunos Therapeutics, For: Oct 04 | SEC filing · Form 8-K | +0.00% | +0.46% | |
| Form 10-Q Alaunos Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | — | -2.89% | |
| Form 8-K/A Alaunos Therapeutics, For: Jul 16 | SEC filing · Form 8-K | +0.00% | +0.81% | |
| Form 8-K Alaunos Therapeutics, For: Jul 16 | SEC filing · Form 8-K | -2.67% | -3.62% | |
| Form 8-K Alaunos Therapeutics, For: Jun 19 | SEC filing · Form 8-K | +0.00% | -8.42% | |
| Form 8-K Alaunos Therapeutics, For: Jun 06 | SEC filing · Form 8-K | +2.04% | -3.06% | |
| Form 10-Q Alaunos Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -4.65% | -7.75% | |
| Form ARS Alaunos Therapeutics, For: Dec 31 | SEC filing · Form ARS | -2.65% | +0.76% | |
| Form DEF 14A Alaunos Therapeutics, For: Jun 06 | SEC filing · Form DEF | -2.65% | +0.76% | |
| Form DEFA14A Alaunos Therapeutics, | SEC filing · Form DEFA14A | -2.65% | +0.76% | |
| Form PRE 14A Alaunos Therapeutics, For: Jun 06 | SEC filing · Form PRE | -3.62% | -6.52% | |
| Form 10-K Alaunos Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -3.31% | |
| Form 8-K Alaunos Therapeutics, For: Feb 15 | SEC filing · Form 8-K | +0.00% | +28.67% | |
| Form 8-K Alaunos Therapeutics, For: Feb 16 | SEC filing · Form 8-K | +5.63% | -7.29% | |
| Form 8-K Alaunos Therapeutics, For: Jan 31 | SEC filing · Form 8-K | +0.43% | -12.12% | |
| Form 8-K Alaunos Therapeutics, For: Jan 29 | SEC filing · Form 8-K | -4.89% | -16.21% | |
| Form 8-K Alaunos Therapeutics, For: Jan 20 | SEC filing · Form 8-K | -0.72% | -3.41% | |
| Form 8-K Alaunos Therapeutics, For: Dec 29 | SEC filing · Form 8-K | -3.59% | +13.03% | |
| Form 8-K Alaunos Therapeutics, For: Dec 22 | SEC filing · Form 8-K | +1.44% | +13.12% | |
| Form 8-K Alaunos Therapeutics, For: Dec 18 | SEC filing · Form 8-K | -1.40% | -1.00% | |
| Form 8-K Alaunos Therapeutics, For: Nov 14 | SEC filing · Form 8-K | +6.34% | +5.63% | |
| Form 10-Q Alaunos Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -3.19% | -18.26% | |
| Form 8-K Alaunos Therapeutics, For: Nov 08 | SEC filing · Form 8-K | -3.19% | -18.26% |
Keep exploring
More TCRT: earnings → · analyst actions → · TCRT overview →